Thermo Fisher Scientific has acquired Intrinsic Bioprobes Inc., a manufacturer of immuno-enrichment, sample preparation tools used in quantitative mass spectrometry, with the intention of offering an enhanced solution for quantitative protein biomarker detection.
Thermo Fisher Scientific has acquired Intrinsic Bioprobes Inc., a manufacturer of immuno-enrichment, sample preparation tools used in quantitative mass spectrometry, with the intention of offering an enhanced solution for quantitative protein biomarker detection.
By adding Intrinsic Bioprobes’ mass spectrometric immunoassay (MSIA) technology to its portfolio, Thermo Fisher will be able to give researchers a complete, higher resolution view of the proteome as the technology allows enrichment of low-abundance proteins in biological samples providing greater specificity and sensitivity and offering clear advantages over ELISA and bead-based immunoassay formats.
“The Intrinsic Bioprobes’ portfolio will enhance Thermo Fisher’s position in the rapidly emerging field of clinical proteomics,” said Chuck Kummeth, president of Thermo Fisher’s laboratory consumables business. “It is a simple, yet powerful approach to uncovering the proteomic basis of disease, and it better positions us to support our customers in their efforts to realize the promise of personalized medicine.”
For further information visit ref="http://www.thermoscientific.com">www.thermoscientific.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Investigating Plastic Contamination in Olive Oil with GC–MS/MS
January 17th 2025The objective of this study was to investigate contamination by 32 plasticizers in olive oil throughout its production and packaging process. Separation and detection were carried out by gas chromatography tandem mass spectrometry (GC–MS/MS), without the need for pre-concentration steps.
Top Execs from Agilent, Waters, and Bruker Take the Stage at J.P. Morgan Healthcare Conference
January 16th 2025The 43rd Annual Healthcare J.P. Morgan Healthcare Conference kicked off in San Francisco earlier this week. Here’s what top executives from Agilent, Bruker, and Waters, discussed during the event.